市場調查報告書
商品編碼
1466362
基於風險的監控軟體市場:按功能、型態和最終用戶分類 - 2024-2030 年全球預測Risk-based Monitoring Software Market by Function (Centralized Monitoring, Reduced Monitoring, Remote Monitoring), Delivery Mode (Cloud-Based, Licensed Enterprise, Web-Based), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
基於風險的監控軟體市場規模預計到2023年為4.0938億美元,到2024年達到4.5294億美元,預計到2030年將達到8.4513億美元,複合年成長率為10.91%。
基於風險的監測 (RBM) 軟體為臨床團隊提供了一個單一平台,可將大量試驗資料流轉化為可操作的分析。 RBM 軟體提高了臨床試驗和項目的品質和合規性。以風險為基礎的監控軟體將臨床實驗地點的資料輸入儀表板,並提醒申辦者需要進一步調查的情況。由於臨床試驗數量的增加以及世界各國政府對藥物發現和開發的財政支持的增加,RBM 軟體的使用正在擴大。然而,實施和安裝 RBM 軟體的高昂成本可能會限制製藥和生物製藥公司的採用。此外,RBM 軟體的進步提高了軟體營運效率,增加了臨床試驗流程的外包,預計將增加製藥公司對 RBM 軟體的採用。
主要市場統計 | |
---|---|
基準年[2023] | 40938萬美元 |
預測年份 [2024] | 4.5294億美元 |
預測年份 [2030] | 84513萬美元 |
複合年成長率(%) | 10.91% |
用於功能性遠端監控活動的基於風險的監控軟體的出現
集中監控是指從一個中心位置對臨床試驗資料和流程進行系統監控。集中監控對於提高資料品質和確保試驗完整性至關重要,而無需進行現場存取。減少監測是指最大限度地減少傳統的現場監測訪問和活動,轉而關注直接影響臨床試驗品質和病人安全的關鍵資料和流程。遠端監控允許CRA(臨床研究助理)審查臨床試驗資料,利用電子手段與臨床試驗地點進行通訊,並在異地進行監控活動。觸發監控是一種自適應方法,可根據透過資料分析確定的特定觸發或風險指標來加強工作。
交付模式:雲端基礎的風險監控軟體交付的進展
雲端基礎的RBM 軟體透過網際網路交付並儲存在供應商的伺服器上。雲端基礎的RBM 模式具有高度的彈性、擴充性和成本效率,特別適合中小型企業 (SME) 和IT基礎設施有限的組織。獲得許可的企業 RBM 軟體安裝並託管在您自己的伺服器上。獲得許可的企業 RBM 軟體交付模式是尋求對其軟體和資料進行完全控制的大型組織的首選。獲得許可的企業 RBM 軟體可以進行客製化並與現有系統整合,使其適合具有複雜監控需求和廣泛 IT 支援的組織。基於Web的RBM軟體可以透過網頁瀏覽器訪問,無需安裝任何軟體。這種類型的交付對於尋求輕鬆存取和使用、最少的 IT 參與和快速部署的組織特別有利。
區域洞察
基於風險的監控 (RBM) 軟體的使用在美洲和歐洲不斷增加。隨著亞太地區增加對藥物發現流程的投資並迅速增加臨床試驗以確定藥物功效和安全性,高效的資料分析和管理解決方案(例如基於風險的監控軟體)的需求不斷成長此外,製藥公司和研究機構正在從委外研發機構(CRO) 外包臨床前服務,以支援具有成本效益的藥物開發。此外,臨床研究機構正在全部區域迅速擴張,為 RBM 軟體部署創造了巨大潛力。 2022年8月,一個新的研究機構—卡明全球流行病治療中心在澳洲成立,旨在開發藥物來治療可能引起全球大流行的病原體引起的疾病。此外,基於風險的軟體的技術進步和改進,以創建可操作的資料集來支援臨床專案和研究,預計將推動全球製藥公司和 CRO 的採用。
FPNV定位矩陣
FPNV 定位矩陣對於評估基於風險的監控軟體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對基於風險的監控軟體市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.基於風險的監控軟體市場的市場規模和預測是多少?
2.在基於風險的監控軟體市場的預測期內,有哪些產品、細分市場、應用程式和領域需要考慮投資?
3.基於風險的監控軟體市場的技術趨勢和法規結構是什麼?
4.基於風險的監控軟體市場主要供應商的市場佔有率是多少?
5. 進入風險監控軟體市場的合適型態和策略手段是什麼?
[196 Pages Report] The Risk-based Monitoring Software Market size was estimated at USD 409.38 million in 2023 and expected to reach USD 452.94 million in 2024, at a CAGR 10.91% to reach USD 845.13 million by 2030.
Risk-based monitoring (RBM) software provides clinical teams with a single platform that transforms numerous study data streams into actionable analytics. RBM software improves the quality and compliance of a clinical trial or program. A risk-based monitoring software feeds data from study sites into a dashboard, which then alerts the sponsor to situations that need further investigation. The increase in the number of clinical trials and financial support from governments worldwide for drug discovery and development is expanding the use of RBM software. However, the high cost of implementation and installation of RBM software may limit their adoption by pharmaceutical and biopharmaceutical companies. Moreover, advancements in RBM software to improve the operational efficiency of the software and growing outsourcing of clinical trial processes are expected to increase the deployment of RBM software across pharmaceutical companies.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 409.38 million |
Estimated Year [2024] | USD 452.94 million |
Forecast Year [2030] | USD 845.13 million |
CAGR (%) | 10.91% |
Function: Emergence of risk-based monitoring softwares for remote monitoring activities
Centralized monitoring entails systematically monitoring clinical trial data and processes from a central location. Centralized monitoring is crucial for enhancing data quality and ensuring trial integrity without the necessity of on-site visits. Reduced monitoring refers to minimizing traditional on-site monitoring visits and activities, focusing instead on critical data and processes that directly impact trial quality and patient safety. Remote monitoring allows CRAs (Clinical Research Associates) to perform their monitoring activities off-site, utilizing electronic means to review trial data and communicate with trial sites. Triggered monitoring is an adaptive approach where efforts are intensified based on specific triggers or indicators of risk identified through data analytics.
Delivery Mode: Advancements in cloud-based delivery of risk-based monitoring softwares
Cloud-based RBM software is delivered over the internet and stored on the provider's servers. The cloud-based RBM model offers high flexibility, scalability, and cost efficiency, making it particularly suitable for small to medium-sized enterprises (SMEs) or organizations with limited IT infrastructure. Licensed enterprise RBM software is installed and hosted on the customer's own servers. Licensed enterprise RBM software delivery mode is preferred by large organizations seeking full control over their software and data. Licensed enterprise RBM software allows for extensive customization and integration with existing systems, suiting organizations with complex monitoring needs and substantial IT support. Web-based RBM software is accessible through a web browser without software installations. This type of delivery is particularly advantageous for organizations seeking ease of access and use, minimal IT involvement, and fast deployment.
Regional Insights
The utilization of risk-based monitoring (RBM) software is increasing in the Americas, and Europe, attributed to the highly developed pharmaceutical sector in the region. The growing investments in the APAC region for the drug discovery process and surge in clinical trials to determine the effectiveness and safety of drugs are raising the need for efficient data analyzing and management solutions such as risk-based monitoring software. Additionally, pharmaceutical companies and research institutions are outsourcing preclinical services from contract research organizations (CROs) to aid the cost-effective development of drugs. Moreover, the rapid expansion of clinical research institutes across the APAC region is creating significant potential for the deployment of RBM software. In August 2022, a new research institute, the Cumming Global Centre for Pandemic Therapeutics, was established in Australia to develop drugs to treat diseases caused by pathogens that could cause global pandemics. Moreover, the technological advancements and improvements in risk-based software for creating actionable datasets to support clinical programs and research are expected to encourage their adoption by pharmaceutical companies and CROs worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Risk-based Monitoring Software Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Risk-based Monitoring Software Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Risk-based Monitoring Software Market, highlighting leading vendors and their innovative profiles. These include Anju Software, Inc., ArisGlobal LLC, CGI Inc., Change Healthcare LLC, Clario, CluePoints S.A., Dassault Systemes S.E., DATATRAK International, Inc., DSG, Inc., eClinical Solutions LLC, ICON PLC, Infosys Limited, International Business Machines Corporation, IQVIA Inc., JMP Statistical Discovery LLC, Laboratory Corporation of America Holdings, LexisNexis Risk Solutions Group, MasterControl Solutions Inc., Mednet, Microsoft Corporation, Octalsoft by Glorant, LLC, Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Scrut Automation, Securitas AB, Signant Health, Sphera Solutions, Inc., TATA Consultancy Services Limited, Veeva Systems Inc., and Wipro Limited.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Risk-based Monitoring Software Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Risk-based Monitoring Software Market?
3. What are the technology trends and regulatory frameworks in the Risk-based Monitoring Software Market?
4. What is the market share of the leading vendors in the Risk-based Monitoring Software Market?
5. Which modes and strategic moves are suitable for entering the Risk-based Monitoring Software Market?